A
Antoni Rafecas
Researcher at University of Barcelona
Publications - 37
Citations - 1274
Antoni Rafecas is an academic researcher from University of Barcelona. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 15, co-authored 37 publications receiving 1196 citations. Previous affiliations of Antoni Rafecas include Bellvitge University Hospital.
Papers
More filters
Journal ArticleDOI
A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
Laura Lladó,Joan Virgili,Joan Figueras,Carles Valls,Joan Dominguez,Antoni Rafecas,Jaume Torras,Joan Fabregat,Jordi Guardiola,Eduardo Jaurrieta +9 more
TL;DR: Transcatheter arterial chemoembolization has been used as a palliative treatment for patients with unresectable hepatocellular carcinoma, but its prognostic usefulness has not previously been clarified.
Journal ArticleDOI
Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation.
Antonia Dalmau,Antoni Sabaté,Fernando Acosta,Lucia Garcia-Huete,Maylin Koo,T Sansano,Antoni Rafecas,Juan Figueras,Eduard Jaurrieta,Pascual Parrilla +9 more
TL;DR: It is found that tranexamic acid, but not epsilon-aminocaproic acid, reduced intraoperative total packed red blood cell transfusion in a prospective, double-blinded study performed in 132 consecutive patients.
Journal ArticleDOI
Management of portal vein thrombosis in liver transplantation: influence on morbidity and mortality.
Laura Lladó,Juan Fabregat,José Castellote,Emilio Ramos,Jaume Torras,Rosa Jorba,Francisco García-Borobia,Juli Busquets,Juan Figueras,Antoni Rafecas +9 more
TL;DR: The aim of this study was to analyze the experience in the management of portal vein thrombosis, and its influence on evolution.
Journal ArticleDOI
Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: Results from a prospective multicenter randomized study ☆
Laura Lladó,Xavier Xiol,Joan Figueras,Emilio Ramos,Roberto Memba,Teresa Serrano,Jaume Torras,Agustin Garcia-Gil,Ignacio Gonzalez-Pinto,José Castellote,Carme Baliellas,Joan Fabregat,Antoni Rafecas +12 more
TL;DR: Immunosuppression without steroids is safe and reduces infection and metabolic complications, and hepatitis C-virus recurrence in liver-transplant patients.
Journal ArticleDOI
The Prophylactic Use of Tranexamic Acid and Aprotinin in Orthotopic Liver Transplantation: A Comparative Study
Antonia Dalmau,Antoni Sabaté,Maylin Koo,Carlos Bartolomé,Antoni Rafecas,Juan Figueras,Eduard Jaurrieta +6 more
TL;DR: In conclusion, administration of regular doses of TA and AP during OLT did not result in large differences between the two groups and there were no intergroup differences in transfusion requirements.